ERGIC3 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP9217a
Background:
ERGIC3 is possible role in transport between endoplasmic reticulum and Golgi.
Other Names:
Endoplasmic reticulum-Golgi intermediate compartment protein 3, Serologically defined breast cancer antigen NY-BR-84, ERGIC3, C20orf47, ERV46, SDBCAG84
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP9217a was selected from the N-term region of human ERGIC3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ERGIC3
Gene ID: 51614
Primary Accession: Q9Y282
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
ERGIC3 is possible role in transport between endoplasmic reticulum and Golgi.
Other Names:
Endoplasmic reticulum-Golgi intermediate compartment protein 3, Serologically defined breast cancer antigen NY-BR-84, ERGIC3, C20orf47, ERV46, SDBCAG84
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP9217a was selected from the N-term region of human ERGIC3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: ERGIC3
Gene ID: 51614
Primary Accession: Q9Y282
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review